Publication | Closed Access

Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis

InflammationRheumatologyTumour Necrosis FactorAutoimmune DiseaseImmunologyPathologyInflammatory MarkerAutoimmunityAutoantibodiesImmunologic DiseaseMedicineAnti-ro52 AutoantibodiesRheumatoid ArthritisSerum Levels